Skip to main content
Clinical Trials/ACTRN12607000591459
ACTRN12607000591459
Completed
Phase 4

A randomised clinical trial to compare the efficacy of intravenous droperidol and olanzepine as adjuncts to midazolam for sedation of the severely agitated patient

Austin Hospital0 sites320 target enrollmentNovember 16, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
severe agitation
Sponsor
Austin Hospital
Enrollment
320
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 16, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Austin Hospital

Eligibility Criteria

Inclusion Criteria

  • Emergecncy department patients who require chemical sedation as determined by an Emergency Physician or a senior registrar.

Exclusion Criteria

  • known hypersensitivity to midazolam, droperidol or olanzepine, reversible aetiology for agitation (hypotension, hypoxia, hypoglycaemia), known pregnancy, acute alcohol withdrawal.

Outcomes

Primary Outcomes

Not specified

Similar Trials